Optolane’s Kaira 2019-nCoV Detection Kit Acquired Singaporean HSA Approval via Provisional Authorization
The Health Sciences Authority (HSA) is committed to ensuring the rapid availability of diagnostic tests for COVID-19 in Singapore. Since 29 January 2020, HSA has been closely providing regulatory and scientific advice to research institutions as well as local and multi-national companies to ensure the timely availability of good quality performing test kits that are critical during this period of need.
See Table below for more information on the diagnostic tests that we have approved to date via provisional authorisation.
Reseouce: Health Sciences Authority of Singapore